Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-20

Clinical Trial Update: Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) in Phase 1/Phase 2, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: RECRUITING